Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4528190
Max Phase: Preclinical
Molecular Formula: C58H94N4O17
Molecular Weight: 1119.40
Molecule Type: Unknown
Associated Items:
ID: ALA4528190
Max Phase: Preclinical
Molecular Formula: C58H94N4O17
Molecular Weight: 1119.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CC(C(=O)NC(C)(C)C)N(CCNC(=O)OC(C)(C)C)C(=O)c2ccccc2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@H]1O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]1OC
Standard InChI: InChI=1S/C58H94N4O17/c1-17-43-39(31-74-55-51(73-16)50(72-15)47(67)36(6)76-55)27-32(2)23-24-41(63)33(3)28-38(49(34(4)42(64)30-44(65)77-43)78-54-48(68)45(61(13)14)46(66)35(5)75-54)29-40(52(69)60-57(7,8)9)62(53(70)37-21-19-18-20-22-37)26-25-59-56(71)79-58(10,11)12/h18-24,27,33-36,38-40,42-43,45-51,54-55,64,66-68H,17,25-26,28-31H2,1-16H3,(H,59,71)(H,60,69)/b24-23+,32-27+/t33-,34+,35-,36+,38-,39-,40?,42-,43-,45+,46-,47+,48-,49-,50+,51+,54+,55+/m1/s1
Standard InChI Key: YPPPIAYDQUIISI-HPFGJKMJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1119.40 | Molecular Weight (Monoisotopic): 1118.6614 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):